Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Ariad Pharmaceuticals Inc. (ARIA)’

dollar-726881_1280

This Billionaire’s Fund Returned 30% This Year; Here Are Some of His Top Stock Picks

Michael Hintze is the founder of multi-strategy asset management firm CQS Cayman. In 2016, Hintze’s CQS Directional Opportunities fund posted a......(read more)
Tesla Motors Inc (NASDAQ:TSLA), Car, Showroom, Customer, Logo, Automotive, Brand, Shop, Sales, Building,

Five Stocks on the Move in the Wake of Trump’s Election Win

After opening rather calmly on the news that Donald Trump is now the President-elect, the markets are down slightly as investors remain cautious on the......(read more)
MNK Q2 16 Ownership

Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns

The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments. This means that retail investors can......(read more)
mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

This Healthcare Fund Just Had A Huge Q3: Here’s How

The mainstream media likes taking shots at hedge funds because they are easy targets. These investment vehicles are usually run by very wealthy individuals......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Ariad Pharmaceuticals, Inc. (ARIA)’s Brigatinib Granted Priority Review

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)‘s lung cancer drug brigatinib has been accepted for review by the FDA. Additionally, the FDA has put the......(read more)
16 Countries That Cheat the Most in the World

Trending Stocks: Diplomat Pharmacy, Facebook, Ariad Pharmaceuticals, and More

Although the broader markets are still down/flat due in large part to Apple Inc. (NASDAQ:AAPL)’s disappointing earnings report, the indexes have......(read more)
Biotech Biochemical Stocks BLRX 3

Tidewater, Inovio, Ariad, and More: What is Going on With These Falling Stocks?

Although the broader markets are in the green today as a wave of M&A activity and a number of solid earnings reports have improved market sentiment......(read more)
Twitter Inc (NYSE:TWTR), Logo, Sign, Phone, Display, Smarphone, Page

Here’s Why These Five Stocks Are in the Spotlight

While the second trading week of the fourth quarter is officially over, several major stocks are trending over the weekend, including Twitter Inc (NYSE......(read more)
Most Consumed Products in the World

Why Apple, Microsoft, Corning, Ariad, and More Are in the Spotlight

The markets are relatively quiet as the latest data shows that durable goods orders in the United States were relatively flat month-over-month in August......(read more)
Image Courtesy Pixabay

Today’s Trending Stocks: Pioneer, Ariad, Hershey, and 2 More

Crude futures are in the red today as sentiment around the commodity cools off. Meanwhile the Dow, Nasdaq, and S&P 500 are relatively flat as traders......(read more)
soil, compost, plant, mix, potassium, phosphorus, nutrient, gardening, garden, nitrogen, green, pile, land, hands, grow, agriculture, field, pellets, chemical, humus,

Why Mosaic, Vale, and Three Other Stocks Are in the Spotlight

Crude futures are well in the green this morning as the worry over a potential ‘Brexit’ diminishes. Although there is a distinct probability......(read more)
FDA Lab

Ariad Pharmaceuticals, Inc. (ARIA) To Seek Regulatory Clearance For Brigatinib In 3Q

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has said that it will file a new drug application (NDA) for its pipeline candidate brigatinib in 3Q2016. This......(read more)
stock, stocks, market, marketing, shares, share, global, chart, bonds, tax, capital, concept, graph, growth, background, rise, statistics, economy, bar, future, loss, business,

Why Tyson Foods, Fitbit, and Three Other Stocks Are Down As Major Indices Are in Green

U.S. markets are trading up in the first day of the week, helped by Janet Yellen’s speech, in which she reiterated the plans to raise the interest......(read more)
accounting, desk, market, funds, economy, business, income, gains, value, wealth, revenue, pen, analysis, foreign, balanced, computer, management, graph, risk, equities, earnings, pie, chart, stocks, money, monetary, high, accountant, growth, low, invest, ratio, quotes, account, workplace, profits, trade, investment, return, office, banking, man, index, financial, hand, businessman, results, performance, exchange, capital

Noteworthy Insider Trading Activity at These 5 Companies as Insider Buying Ratio Increases

Last week’s dollar volume of all insider purchases almost doubled week-over-week, whereas the volume of insider selling decreased quite meaningfully......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Five Cheap Healthcare Stocks With Hedge Fund Support

When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare. The healthcare universe boasts of several companies......(read more)
Jeff Ubben VALUEACT CAPITAL

Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Meister Cuts Stake in This REIT, Plus 2 Other Moves

Fresh data shows that 2015 was the year with the highest number of hedge fund closures since the financial crisis, as increased volatility in equity markets......(read more)
money, expensive, medical, examination, patient, business, concept, clinic, stethoscope, wealth, insurance, finance, dollar, disease, bank, treatment, sick, medicine,

Five Cheap Healthcare Stocks Poised to Explode

Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Why Are These Stocks Among Today’s Losers?

This week’s roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.......(read more)
Tarchyshnik Andrei/shutterstock.com

5 Healthcare Stocks Under $10 Ready To Pop

Investing in the healthcare sector can be tricky, especially if you’re looking for high returns and want to invest in clinical-stage companies,......(read more)
Biotech Stocks 9

Hedge Funds Like Ariad Pharmaceuticals, Inc. (ARIA) Despite the Failed Deal

Less than a week after reports that Baxalta Inc (NYSE:BXLT) wanted to acquire Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), the discussions of a deal......(read more)
cheerful pharmacist chemist woman standing in pharmacy drugstore

The Good, The Bad, And The Ugly: A Journey Into Jonathan Soros’ Top Small-Cap Picks

JS Capital Management is a New York-based hedge fund founded and led by Jonathan Soros. Soros, son of legendary hedge fund manager George Soros, used......(read more)
Alex Denner Sarissa Capital

Hedge Fund News: Alex Denner, Steven Tananbaum, Bill Ackman

Ariad Pharma CEO ‘Retires’ in Settlement With Activist Hedge Fund (The Street) Ariad Pharmaceuticals founder and CEO Harvey Berger is exiting......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market

Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc., Quest Diagnostics Inc, Amgen, Inc.: Sarissa Capital’s Top Stock Picks and New Moves

Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F Form filed with the U.S. Securities......(read more)
Alex Denner Sarissa Capital

Townsquare Media Inc, Aegerion Pharmaceuticals, Inc.: Tricadia Capital Increases Stake; Sarissa Capital Enters New Position

Michael Barnes And Arif Inayatullah’s Tricadia Capital Management recently disclosed an increase to its position in Townsquare Media Inc (NYSE:TSQ)......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc. (ARIA): Healthcare-focused Sarissa Capital Inches Up Its Stake to 6.87%

As a new filing with the Securities and Exchange Commission showed, Sarissa Capital Management, a fund led by Alex Denner, has picked up its position......(read more)
Alex Denner Sarissa Capital

Activist Alex Denner’s Sarissa Capital Bets on Ariad Pharmaceuticals Inc (ARIA), Quest Diagnostics Inc (DGX) & Others

Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings. The hedge fund has invested $267.02 million in equity portfolio......(read more)
best gold ETF

Hedge Fund News: John Paulson, Marc Faber & Warren Buffett

Hedge Funds Dodge Brunt of Selloff as Dalio to Paulson Gain (BusinessWeek) Hedge funds held up better than global stocks last month, falling an average......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Former Icahn MD’s Sarissa Capital Discloses 6.2% of Ariad Pharmaceuticals

According to a new filing with the SEC, Sarissa Capital Management now holds around 11.5 million shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA),......(read more)
Santarus, Inc. (NASDAQ:SNTS)

Santarus, Inc. (SNTS), Pharmacyclics, Inc. (PCYC), Ariad Pharmaceuticals, Inc. (ARIA): Should You Jump on This Biotech After Profit-Taking?

After a truly remarkable 20-month 650% gain, shares of Santarus, Inc. (NASDAQ:SNTS) have fallen by more than 20% since its all-time high in early August......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does This Orphan Leukemia Treatment Have Blockbuster Potential?

When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen. However, more speculative......(read more)
Seattle Genetics, Inc. (NASDAQ:SGEN)

Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?

At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......(read more)
Third Point 2014 Q3 Investor Letter

Elan Corporation, plc (ADR) (ELN), Tibco Software Inc. (TIBX): What This 758% Gainer Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)
Santarus, Inc. (NASDAQ:SNTS)

Santarus, Inc. (SNTS), Aegerion Pharmaceuticals, Inc. (AEGR), Ariad Pharmaceuticals, Inc. (ARIA): Did a Strong New Drug Make This Biotech Overvalued?

Santarus, Inc. (NASDAQ:SNTS) has risen over 300% in the past year partly based on sales optimism for ulcerative colitis drug Uceris, which launched in......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

This Metric Says You Are Smart to Sell Ariad Pharmaceuticals, Inc. (ARIA)

In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......(read more)
Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ:JAZZ)

Should You Avoid Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)?

In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge......(read more)
Medivation Inc (NASDAQ:MDVN)

What Hedge Funds Think About Medivation Inc (MDVN)

Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......(read more)
American Capital Agency Corp. (NASDAQ:AGNC)

Real Estate News: Annaly Capital Management, Inc. (NLY) New CFO, American Capital Agency Corp. (AGNC)’s Put Options, American Capital Ltd. (ACAS) Percentage Change

Editor’s Note: Annaly Capital Management, Inc. (NYSE:NLY), American Capital Agency Corp. (NASDAQ:AGNC), American Capital Ltd. (NASDAQ:ACAS) CFO......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), Bristol-Myers Squibb Co (BMY): The Most Important Number for This Drug Launch

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) gave investors a closer look at how the launch of its leukemia drug Iclusig is going when it released second......(read more)
Santarus, Inc. (NASDAQ:SNTS)

Santarus, Inc. (SNTS), Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ): Three Earning Catalysts That Could Push This Biotech Even Higher

Santarus, Inc. (NASDAQ:SNTS) has traded higher by 250% over the last year, and much of those gains have been created after the company’s last two quarterly......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Pharmacyclics, Inc. (PCYC): Will This Biotech Acquisition Buzz Lead to More Buyouts?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is trading higher after rejecting a takeover bid. As other stocks in its sector also trade higher in sympathy......(read more)
Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Celldex Therapeutics, Inc. (CLDX) On The Rise

There are many biotech stocks that target cancer, but what is good about Celldex Therapeutics, Inc. (NASDAQ:CLDX) is that it is targeting many therapeutic......(read more)
Galena Biopharma Inc

Galena Biopharma Inc (GALE): Should You Buy the Hype Surrounding This Product Launch?

While the analysis of peak sales and potential patient populations may be appealing to most, it costs a great deal of money to launch a new product with......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), VIVUS, Inc. (VVUS): Winning Biotech Investment Strategies and Their Potential Pitfalls

Investing in biotech companies isn’t without its challenges, but it doesn’t have to be a shot in the dark, either. With a little bit of study......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches

There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-......(read more)
Bristol Myers Squibb Co. (NYSE:BMY)

Bristol Myers Squibb Co. (BMY), Ariad Pharmaceuticals, Inc. (ARIA): ASCO Investment Ideas

The American Society of Clinical Oncology annual meeting kicks off today. The scientific conference is the premier place for oncology companies to present......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Here is What Hedge Funds Think About Ariad Pharmaceuticals, Inc. (ARIA)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shareholders have witnessed an increase in activity from the world’s largest hedge funds of late. To the......(read more)

Yahoo! Inc. (YHOO), Virgin Media Inc. (VMED): Here’s What This 758% Gainer Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

MannKind Corporation (MNKD)’s Run to Glory

Shares of MannKind Corporation (NASDAQ:MNKD) have nearly tripled over the last year. The value of the biotech is up a whopping 584% when you look at......(read more)